Positron Emission Tomography

News Positron Emission Tomography

• Eckert & Ziegler obtains manufacturing authorization for pharmaceutical Gallium-68 generators

  Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG, has been given the manufacturing authorization for its pharmaceutical 68Ge/68Ga generators at the newly-built, GMP-compliant manufacturing facilities in Berlin. The authorization given by the local German competent authority all more

• Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb

  Oxford BioMedica plc  announced that it has signed a research collaboration agreement with ImaginAb, Inc., a biotechnology company specialising in the development of engineered antibody fragments for diagnostic imaging and  therapeutic applications, to engineer an in vivo diagnostic imaging agent us more

• BioInvent announces approval to start Phase II trial for its novel cardiovascular drug BI-204

  BioInvent International AB announced IND clearance from the U.S. Food & Drug Administration (FDA) to initiate a Phase II study for BI-204. BI-204 is a human monoclonal antibody that specifically targets oxidized forms of a low-density lipoprotein (LDL) which has been linked to increased inflammatory more

Publications Positron Emission Tomography

• [18F]‐FBEM, a tracer targeting cell‐surface protein thiols for cell trafficking imaging

  We used [18F]‐4‐fluorobenzamido‐N‐ethylamino‐maleimide ([18F]‐FBEM) to radiolabel cells ex vivo for in vivo positron emission tomography (PET) in order to assess cell trafficking in mice. In contrast to commonly used imaging agents, [18F]‐FBEM forms a covalent bond with thiol groups present on the more

• 19F/18F exchange synthesis for a novel [18F]S1P3‐radiopharmaceutical

  19F/18F isotope exchange is a useful method to label drug molecules containing 19F‐fluorine with 18F without modifying the drug molecule itself. Sphingosine‐1‐phosphate (S1P) is an important cellular mediator that functions by signaling through cell surface receptors. S1P is involved in several ce more

• Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy Outcome

  by Yukie Yoshii, Takako Furukawa, Nobuyuki Oyama, Yoko Hasegawa, Yasushi Kiyono, Ryuichi Nishii, Atsuo Waki, Atsushi B. Tsuji, Chizuru Sogawa, Hidekatsu Wakizaka, Toshimitsu Fukumura, Hiroshi Yoshii, Yasuhisa Fujibayashi, Jason S. Lewis, Tsuneo Saga Fatty acid synthase (FASN) expression is elevat more

Market studies Positron Emission Tomography

• Diagnostic Imaging Market to 2017 - Fusion Technology to Increase Adoption Rates of Hybrid Imaging Systems

  GBI Research’s report, “Diagnostic Imaging Market to 2017 - Fusion Technology to Increase Adoption Rates of Hybrid Imaging Systems” provides information and analysis on the global diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on more

• Medical Imaging Market Report: 2012 Edition

  Medical imaging market, which represents the largest segment within the global medical devices market, has witnessed significant growth in the last decade and the trend is set to persist in the foreseeable future. Medical imaging market consists of X-ray, Ultrasound, Computed Tomography, Positron Em more

• Diagnostic Imaging International Corp. - Strategic SWOT Analysis Review

  Diagnostic Imaging International Corp. (DIIC) is a US based medical device company. The company was formerly known as Galloway Investments Corp. It is a development-stage company planning to acquire and operate diagnostic imaging clinics including Magnetic Resonance Imaging (MRI) clinics, Computed T more

Websites Positron Emission Tomography